Rice Hall James & Associates’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.48M Sell
113,589
-974
-0.9% -$56.5K 0.36% 70
2025
Q4
$5.8M Sell
114,563
-7,419
-6% -$379K 0.32% 77
2025
Q3
$6.1M Sell
121,982
-23,485
-16% -$1.08M 0.33% 74
2025
Q2
$5.82M Sell
145,467
-6,351
-4% -$237K 0.31% 75
2025
Q1
$5.32M Sell
151,818
-965
-0.6% -$38K 0.31% 71
2024
Q4
$5.97M Buy
+152,783
New +$5.49M 0.33% 70
2016
Q4
Sell
-270,386
Closed -$16.2M 307
2016
Q3
$16.2M Sell
270,386
-1,420
-0.5% -$81.7K 0.85% 52
2016
Q2
$15.6M Buy
271,806
+118,787
+78% +$7.93M 0.9% 47
2016
Q1
$11.8M Buy
+153,019
New +$9.88M 0.68% 60

Other funds holding PRLB

Rice Hall James & Associates's PRLB Position: Q1 2026 in Review

Rice Hall James & Associates reduced its Protolabs (PRLB) stake by 0.85% in Q1 2026, selling an estimated $56.5K and leaving 113,589 shares worth $6.48M. The position accounts for 0.36% of the portfolio, ranked #70.

Rice Hall James & Associates first reported a position in PRLB in Q1 2016 and has held it in 9 quarters since. The position peaked at $16.2M in Q3 2016. 262 funds tracked by Wall St. Rank hold PRLB as of Q1 2026.

  • Rice Hall James & Associates held 113,589 shares of Protolabs worth $6.48M as of Q1 2026.
  • Rice Hall James & Associates sold 974 Protolabs shares in Q1 2026, an estimated $56.5K.
  • Protolabs made up 0.36% of Rice Hall James & Associates's portfolio in Q1 2026, its #70 holding.
  • Rice Hall James & Associates first reported a position in Protolabs in Q1 2016 and has held it in 9 quarters since.
  • Rice Hall James & Associates's Protolabs position peaked at $16.2M in Q3 2016.
  • 262 funds tracked by Wall St. Rank held Protolabs as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.